31 related articles for article (PubMed ID: 22627630)
21. Histopathology of Prostate Cancer.
Humphrey PA
Cold Spring Harb Perspect Med; 2017 Oct; 7(10):. PubMed ID: 28389514
[TBL] [Abstract][Full Text] [Related]
22. Histological patterns, subtypes and aspects of prostate cancer: different aspects, different outcomes.
Wasinger G; Oszwald A; Shariat SF; Compérat E
Curr Opin Urol; 2022 Nov; 32(6):643-648. PubMed ID: 36081403
[TBL] [Abstract][Full Text] [Related]
23. Morphologic and molecular prognostic markers in prostate cancer.
Ross JS; Sheehan CE; Dolen EM; Kallakury BV
Adv Anat Pathol; 2002 Mar; 9(2):115-28. PubMed ID: 11917165
[TBL] [Abstract][Full Text] [Related]
24. Analysis of IMP3 expression in prostate adenocarcinomas.
Tosun Yildirim H; Sentürk N
Turk Patoloji Derg; 2012; 28(2):128-33. PubMed ID: 22627630
[TBL] [Abstract][Full Text] [Related]
25. Changes in biomarker expression in the development of prostatic adenocarcinoma.
Myers RB; Grizzle WE
Biotech Histochem; 1997 Mar; 72(2):86-95. PubMed ID: 9152521
[TBL] [Abstract][Full Text] [Related]
26. Prostate pathology: histologic and molecular perspectives.
Putzi MJ; De Marzo AM
Hematol Oncol Clin North Am; 2001 Jun; 15(3):407-21. PubMed ID: 11525288
[TBL] [Abstract][Full Text] [Related]
27. Molecular biology of prostatic intraepithelial neoplasia.
Bostwick DG; Pacelli A; Lopez-Beltran A
Prostate; 1996 Aug; 29(2):117-34. PubMed ID: 8700801
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.
Findeis-Hosey JJ; Xu H
Biotech Histochem; 2012 Jan; 87(1):24-9. PubMed ID: 21838610
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetic aspects of prostate transition zone lesions.
Pavelić J; Zeljko Z; Bosnar MH
Urology; 2003 Oct; 62(4):607-13. PubMed ID: 14550426
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]